Dexmedetomidine for heart protection after a specific heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether dexmedetomidine can protect the heart in people who are having a specific type of heart attack (anterior STEMI) when treated within 6 hours of symptom start. You may be considered if your diagnosis and vital signs fit the study safety rules, and if you can take part in follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 to 75 (including both ages).
- Have an anterior STEMI heart attack diagnosed within 6 hours of symptom onset.
- Your ECG must show ST elevation (≥0.2 mV) in 2+ nearby chest leads, including V2/V3/V4.
- Be able and willing to sign the informed consent form.
- Not have any major safety exclusions, such as severe shock, dangerous rhythm problems, or very low oxygen.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding a medication called dexmedetomidine during cancer surgery can improve long-term survival. It is for older adults having major cancer surgery that lasts at least two hours and who will need a pain pump after the operation.
This study tests whether a sedative given as a nasal spray before a heart procedure (angioplasty) can reduce heart damage. It may help people with heart disease who are having this procedure.
This study tests whether a sedative given as a nasal spray (called dexmedetomidine) can help protect your heart during a planned procedure to open blocked heart arteries. If you are having this procedure, the medication may reduce the risk of heart damage afterward.
This trial tests whether a drug called dexmedetomidine, given during general anesthesia, helps keep your heart rate and blood pressure stable during outpatient surgery. It may be an option if you are having a minor surgery and are not on certain heart medications.
This study looks at how a sleep medicine called dexmedetomidine affects thinking and memory after heart surgery. It compares cognitive outcomes over time to see if this sedation choice changes long-term brain function.
This trial tests whether a sedating medicine called dexmedetomidine can reduce the risk of “delirium” (sudden confusion) in the intensive care unit after open-heart surgery. If you’re having certain heart operations, it may help protect your thinking and alertness during recovery.
Hear when a new ST-segment Elevation Myocardial Infarction (STEMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.